About the International Journal of Glaucoma

IJG considers all glaucoma research: basic, translational, clinical, surgical, device-related and epidemiological studies. Pathophysiology is a core area, from retinal ganglion cell degeneration and aqueous outflow to the biomechanics of the optic nerve head, and the journal equally welcomes work on diagnosis, imaging, medical and surgical treatment, and the outcomes that matter to patients.

Its aims are to publish methodologically sound research that advances understanding of glaucoma, to support the tools and methods used to detect and monitor it, and to make the results freely available to everyone who can use them.

The Aims and Scope page describes the scope, study designs and eligibility in full.

Article types

• Original Research
• Review
• Systematic Review and Meta-Analysis
• Methods
• Short Communication
• Case Report
• Clinical Case Image
• Commentary
• Letter

Preparation guidance for each type is given in the Instructions for Authors.

Editorial responsibility

The Editor-in-Chief leads the journal's editorial direction and oversees its decisions, supported by an international editorial board of researchers and clinicians who handle manuscripts within their expertise and advise on the journal's scope and policies.

Editorial decisions are based on scope, scientific quality, methodological rigor, ethical compliance, reporting quality, and relevance to the journal. They are independent of the article processing charge and of any fee-relief inquiry. Editors with a conflict of interest are recused from handling the manuscript.

Peer review

All submissions undergo initial editorial screening. Manuscripts that meet the journal's scope and minimum requirements proceed to independent peer review. Single-blind by default; double-blind review is available on request. Manuscripts that proceed to external peer review are normally evaluated by at least two independent subject-matter experts. The full process is set out in the Editorial Policies.